Effect of St. John's wort on free radical production

被引:88
作者
Hunt, EJ [1 ]
Lester, CE [1 ]
Lester, EA [1 ]
Tackett, RL [1 ]
机构
[1] Univ Georgia, Coll Pharm, Dept Clin & Adm Sci, Athens, GA 30602 USA
关键词
St. John's wort; antioxidant; free radical; depression; human tissue; superoxide;
D O I
10.1016/S0024-3205(01)01102-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
St. John's wort (Hypericum perforatum) is an herbal compound used in the treatment of burns, bruises, swelling, anxiety, and most recently, mild to moderate depression. The present study was designed to evaluate the antioxidant properties of St. John's wort in both cell-free and human vascular tissue. The experiment was performed initially in a cell-free system using Krebs buffer and a combination of xanthine/xanthine oxidase to initiate the production of the superoxide radical. Additionally, human placental vein was incubated in Krebs buffer without xanthine or xanthine oxidase to study the effects of St. John's wort on human tissue in vitro. Commercially available formulations of St. John's wort, standardized to either hypericin or hyperforin, were dissolved in an alkaline solution, and the following dilutions were made: 1:1, 1:2.5, 1:5, 1:7.5, 1:10, and 1:20. Lucigenin chemiluminescence was used to measure free radical production in both systems. A pro-oxidant effect was seen at the highest concentration, 1:1. Lower concentrations revealed antioxidant properties of the compound. All dilutions below 1:1 in both systems showed a dose-related inverse relationship of superoxide inhibition. The largest suppression was seen at the most dilute concentration, 1:20. The addition of 10(-3) M tiron inhibited the chemiluminescence signal, thereby confirming the production of superoxide. The results of this study suggest that St. John's wort inhibits free radical production in both cell-free and human vascular tissue. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 39 条
[1]  
[Anonymous], [No title captured]
[2]   Activity profiles of two hyperforin-containing Hypericum extracts in behavioral models [J].
Bhattacharya, SK ;
Chakrabarti, A ;
Chatterjee, SS .
PHARMACOPSYCHIATRY, 1998, 31 :22-29
[3]   Oral bioavailability of hyperforin from Hypericum extracts in rats and human volunteers [J].
Biber, A ;
Fischer, H ;
Romer, A ;
Chatterjee, SS .
PHARMACOPSYCHIATRY, 1998, 31 :36-43
[4]  
Bombardelli Ezio, 1995, Fitoterapia, V66, P43
[5]   ABSENCE OF RELATIONSHIP BETWEEN ANTIARRHYTHMIC EFFECTS OF ANTIDEPRESSANT DRUGS AND LIPID-PEROXIDATION [J].
BRIL, A ;
ABADIE, C ;
BENBAOUALI, A ;
MAUPOIL, V ;
ROCHETTE, L .
PHARMACOLOGY, 1993, 46 (01) :23-32
[6]   Hyperforin as a possible antidepressant component of hypericum extracts [J].
Chatterjee, SS ;
Bhattacharya, SK ;
Wonnemann, M ;
Singer, A ;
Müller, WE .
LIFE SCIENCES, 1998, 63 (06) :499-510
[7]   Antidepressant activity of Hypericum perforatum and hyperforin: The neglected possibility [J].
Chatterjee, SS ;
Noldner, M ;
Koch, E ;
Erdelmeier, C .
PHARMACOPSYCHIATRY, 1998, 31 :7-15
[8]   In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine [J].
Colado, MI ;
OShea, E ;
Granados, R ;
Murray, TK ;
Green, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (05) :889-900
[9]  
Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154
[10]   Effect of some psychotropic drugs on the activated macrophage-induced luminol-dependent chemiluminescence [J].
Hadjimitova, V ;
Traykov, T ;
Goliysky, P ;
Ribarov, S .
PHARMACOLOGY & TOXICOLOGY, 1999, 84 (04) :170-173